TOR2/YKL203C Literature Guide Help

Other names published for TOR2: DRR2, YKL203C

TOR2 - Non-Fungal Related Genes/Proteins (38)

ReferenceOther Genes Addressed
Evans DS, et al.  (2011) TOR signaling never gets old: Aging, longevity and TORC1 activity. Ageing Res Rev 10(2):225-37
Hardt M, et al.  (2011) Activating mutations of TOR (target of rapamycin). Genes Cells 16(2):141-51
van Dam TJ, et al.  (2011) Evolution of the TOR pathway. J Mol Evol 73(3-4):209-20
Foster DA, et al.  (2010) Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s). Genes Cancer 1(11):1124-31
Kamada Y, et al.  (2010) Tor directly controls the Atg1 kinase complex to regulate autophagy. Mol Cell Biol 30(4):1049-58
Rigden DJ, et al.  (2009) Autophagy in protists: Examples of secondary loss, lineage-specific innovations, and the conundrum of remodeling a single mitochondrion. Autophagy 5(6):784-94
Sturgill TW and Hall MN  (2009) Activating mutations in TOR are in similar structures as oncogenic mutations in PI3KCalpha. ACS Chem Biol 4(12):999-1015
Diaz-Troya S, et al.  (2008) Target of rapamycin and LST8 proteins associate with membranes from the endoplasmic reticulum in the unicellular green alga Chlamydomonas reinhardtii. Eukaryot Cell 7(2):212-22
Jacinto E and Lorberg A  (2008) TOR regulation of AGC kinases in yeast and mammals. Biochem J 410(1):19-37
Meijer WH, et al.  (2007) ATG genes involved in non-selective autophagy are conserved from yeast to man, but the selective Cvt and pexophagy pathways also require organism-specific genes. Autophagy 3(2):106-16
Miranda-Saavedra D and Barton GJ  (2007) Classification and functional annotation of eukaryotic protein kinases. Proteins 68(4):893-914
Satish Kumar V, et al.  (2007) Optimization based automated curation of metabolic reconstructions. BMC Bioinformatics 8:212
Dann SG and Thomas G  (2006) The amino acid sensitive TOR pathway from yeast to mammals. FEBS Lett 580(12):2821-9
De Virgilio C and Loewith R  (2006) The TOR signalling network from yeast to man. Int J Biochem Cell Biol 38(9):1476-81
Mayer C and Grummt I  (2006) Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 25(48):6384-91
Takahara T, et al.  (2006) Nutrient-dependent Multimerization of the Mammalian Target of Rapamycin through the N-terminal HEAT Repeat Region. J Biol Chem 281(39):28605-14
Martin DE and Hall MN  (2005) The expanding TOR signaling network. Curr Opin Cell Biol 17(2):158-66
Rodriguez-Escudero I, et al.  (2005) Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast. Biochem J 390(Pt 2):613-23
Jacinto E, et al.  (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6(11):1122-8
Lindsley JE and Rutter J  (2004) Nutrient sensing and metabolic decisions. Comp Biochem Physiol B Biochem Mol Biol 139(4):543-59
Lorberg A and Hall MN  (2004) TOR: the first 10 years. Curr Top Microbiol Immunol 279():1-18
Otto GP, et al.  (2003) Macroautophagy is required for multicellular development of the social amoeba Dictyostelium discoideum. J Biol Chem 278(20):17636-45
Loewith R, et al.  (2002) Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell 10(3):457-68
Morrison HG, et al.  (2002) Inferring protein function from genomic sequence: Giardia lamblia expresses a phosphatidylinositol kinase-related kinase similar to yeast and mammalian TOR. Comp Biochem Physiol B Biochem Mol Biol 133(4):477-91
Aoki H, et al.  (2000) Characterization of Ce-atl-1, an ATM-like gene from Caenorhabditis elegans. Mol Gen Genet 264(1-2):119-26
Kumar V, et al.  (2000) Functional interaction between RAFT1/FRAP/mTOR and protein kinase cdelta in the regulation of cap-dependent initiation of translation. EMBO J 19(5):1087-97
Oldham S, et al.  (2000) Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. Genes Dev 14(21):2689-94
Zhang H, et al.  (2000) Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev 14(21):2712-24
Vessey CJ, et al.  (1999) Genetic disorders associated with cancer predisposition and genomic instability. Prog Nucleic Acid Res Mol Biol 63():189-221
Alarcon CM, et al.  (1996) Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast. Genes Dev 10(3):279-88